Warantec Co., Ltd. (주식회사 워랜텍) - Korea's Leading Dental Implant Manufacturer with Academic Heritage

Company Overview (Updated April 2026)

Warantec Co., Ltd. (주식회사 워랜텍) is a leading Korean dental implant manufacturer headquartered in Seongnam, Gyeonggi Province, South Korea. Founded in 2001 by professors from Korea's top three dental universities, the company originated from the Korean government's G7 Project (1995) aimed at developing a domestic dental implant system. Warantec has established itself as a clinically driven implant company with over 20 years of clinical data, supplying products to major university hospitals including Seoul National University Dental Hospital and Gangnam Severance Hospital.

Corporate Philosophy: "An implant company that prioritizes clinical applications and endless research & development" – Warantec maintains an unwavering focus on R&D, quality innovation, and clinical validation before product launch.

History & Development

Key Milestones:

- 1995: Initiated as a government G7 Project supported by the Ministry of Health and Welfare, involving professors from Seoul National University, Yonsei University, and Catholic University

- 2001: Company officially founded based on the G7 Project research outcomes; commenced development of domestic dental implant systems

- 2001-2019: Established clinical track record; developed proprietary SLA (Sandblasted, Large-grit, Acid-etched) surface technology with optimal RA value of 1.44μm

- July 2019: Straumann Group acquired 33.5% stake and secured exclusive distribution rights outside Korea; Yuhan Corporation maintained controlling stake

- 2024: Yuhan Corporation divested entire 34.4% shareholding (3.2 million shares) to undisclosed buyers; reported net profit of approximately KRW 700 million in the previous fiscal half-year

- 2025: Partnered with AIDITE for digital dentistry solutions; launched aggressive marketing campaign targeting Middle East markets

- 2026: Targeting 30%+ revenue growth with focus on Middle East expansion

Shareholder Structure & Strategic Partnerships

Ownership (as of 2026)

- Straumann Group (Switzerland): 33.5% shareholding with exclusive international distribution rights outside Korea

- Dentist Shareholders: Approximately 100 dentists hold shares through private placement

- Yuhan Corporation: Divested all shares (34.4%, previously controlling stakeholder) in 2024

Strategic Alliance with Straumann

Since 2019, Straumann has provided capital injection to build Warantec's production capacity and international business infrastructure. The partnership includes development of a training academy and KOL (Key Opinion Leader) network. Warantec serves as Straumann's strategic brand for the non-premium segment in Asian markets where Korean manufacturers hold competitive advantages.

Product Portfolio

Core Implant Systems

Oneplant System (Flagship):

- Fully tapered and apically tapered implant designs

- Designed for simplicity, affordability, and clinical reliability

- Available in bone level and tissue level configurations

- Korea's first Onebody implant system with high success rates

HT Implant System:

- 7° Connection IT Implant: External hex connection with 1mm height to reduce screw loosening complications

- Dual hex-fit design for improved prosthetic directionality on angled abutments

- Progressive Power Thread with V-shaped self-tapping design

IU Implant System (Aesthetic Line):

- 11° Internal Hex Connection: Non-connection integral implant system eliminating micro-movement

- Tapered body with straight thread angle combined with tapered shape

- Micro-thread (400μm) design for increased bone density and secondary stability

- SLA (ABE) Surface: Advanced Blasting & Etching with optimal 1.44μm roughness

UT Implant System:

- Onebody-type mini implant for narrow ridge and mandibular anterior cases

- Friction-Lock Connect technology for cementless abutment connection

- Suitable for flapless surgery and temporary implants

InEx System:

- Specialized extraction and immediate placement system

Digital Dentistry Solutions

- CAD/CAM Integration: Digital workflows compatible with modern dental scanners and milling systems

- Prosthetic Components: Comprehensive range including impression copings, scan bodies, multi-unit abutments, titanium bases, Locator attachments, and ball attachments

- Surgical Kits: Specialized drilling protocols and instrumentation for each implant system

Technology & Innovation

Proprietary SLA Surface Technology

Warantec's ABE (Advanced Blasting & Etching) surface treatment achieves an optimal RA roughness value of 1.44μm with round and uniform surface texture. This proprietary SLA technology minimizes sharp particles while maximizing osseointegration potential, recognized by Korean dental academia since product launch.

Clinical Validation

- 20+ years of clinical data accumulated since inception

- Pre-market clinical testing involving practicing clinicians (dentists) before product launch

- Publications in distinguished US journals

- Full clinical track record from Seoul National University Dental Hospital and Gangnam Severance Dental Hospital

Market Position & Performance

Domestic Market Share (Korea)

- Market Position: Approximately 10th place in Korean implant market

- Market Share: 0.62% (as of 2020 data), competing against Osstem (dominant leader), Dentium, NeoBiotech, and Dio

- Key Competitors: Osstem Implant, Dentium, NeoBiotech, Megagen, Dio Implant

International Expansion (2025-2026)

- 2025 Performance: Targeting 30%+ revenue growth through aggressive marketing activities

- Middle East Focus: CEO Shim In Bo announced Middle East market drive as key strategy for 2025-2026

- Distribution Network: Present in over 12 countries

- Key Markets: Europe (Germany, Switzerland via Algess Group), USA, China, India, and Southeast Asia

- Straumann Distribution: Exclusive global distribution rights outside Korea through Straumann Group's infrastructure

Corporate Information (2026)

Company Profile

Company Name: Warantec Co., Ltd. (주식회사 워랜텍)

Founded: 2001 (originated from 1995 G7 Project)

Headquarters: 4F, 411-412, Seongnam-si, Jungwon-gu, Dunchon-daero 474, Gyeonggi-do, Republic of Korea (Postal: 13200)

Business Registration No.: 215-86-18799

CEO: Shim In Bo (심인보)

Employees: Approximately 30 (2019 baseline)

Industry: Dental Medical Device Manufacturing

Website: www.warantec.co.kr / www.warantec.com

Contact Information

Tel: +82-2-3675-5851

Fax: +82-2-3675-5853

Email: info@warantec.com

Global Network: Exclusive distributors in Switzerland and Germany (Algess Group AG), plus distribution partnerships in 12+ countries via Straumann network

2026 Outlook

Strategic Directions

- Post-Yuhan Independence: Operating as an independent entity with Straumann partnership following Yuhan's 2024 divestiture

- Middle East Expansion: Aggressive market penetration in Middle Eastern countries as primary growth driver for 2025-2026

- Digital Transformation: Expanding digital dentistry solutions through partnerships like AIDITE collaboration

- Global Growth: Leveraging Straumann's distribution network to achieve 30%+ revenue growth target

- Product Innovation: Continuing R&D investment in surface technology, Onebody systems, and minimally invasive implant solutions

Key Differentiators

- Academic Heritage: Only Korean implant company founded directly from a government research project involving Seoul National, Yonsei, and Catholic University dental professors

- Clinical-First Approach: All products undergo extensive pre-market clinical validation with practicing clinicians

- Dual Partnership Strategy: Unique position with both local pharmaceutical heritage (formerly Yuhan) and global implant leader backing (Straumann)

- Cost-Competitiveness: Positioned in the value segment while maintaining premium quality standards, making implants accessible for broader patient populations

- Proven Longevity: Over 20 years of clinical data supporting product efficacy and safety

Keywords: Warantec,워랜텍,dental implant,Oneplant,HT implant,IU implant,UT implant,SLA surface,ABE technology,Straumann,Yuhan Corporation,G7 Project,Korean implant,internal hex,external hex,osseointegration,digital dentistry,Middle East expansion,Shim In Bo